Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-04-22 Purchase |
2024-04-24 6:31 pm |
GlucoTrack Inc. | GCTK | SYCOFF DREW Director 10% Owner |
182,540 | $1.26 | $230,000 | 2,951,258 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-11-14 Other |
2025-03-31 09:20 am |
N/A N/A |
Glucotrack Inc. | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner |
132,036 | $31 | 3,381,817 (Direct) |
View |
2025-03-12 Exercise |
2025-03-31 09:20 am |
2025-01-03 2027-07-03 |
Glucotrack Inc. | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner |
2,692,589 | $0 | 3,381,817 (Direct) |
View |
2024-11-14 Option Award |
2025-03-31 09:20 am |
2025-01-03 2030-01-03 |
Glucotrack Inc. | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner |
264,072 | $0 | 3,381,817 (Direct) |
View |
2024-11-14 Other |
2025-03-31 08:54 am |
N/A N/A |
Glucotrack Inc. | GCTK | BALLANTYNE JOHN Director 10% Owner |
132,036 | $31 | 3,385,943 (Indirect) |
View |
2025-03-12 Exercise |
2025-03-31 08:54 am |
2025-01-03 2027-07-03 |
Glucotrack Inc. | GCTK | BALLANTYNE JOHN Director 10% Owner |
2,692,589 | $0 | 3,385,943 (Indirect) |
View |
2024-11-14 Option Award |
2025-03-31 08:54 am |
2025-01-03 2030-01-03 |
Glucotrack Inc. | GCTK | BALLANTYNE JOHN Director 10% Owner |
268,198 | $0 | 3,385,943 (Indirect) |
View |
2025-03-12 Exercise |
2025-03-31 08:17 am |
2030-01-03 2027-07-03 |
Glucotrack Inc. | GCTK | Malave Luis Director |
140,418 | $0 | 357,389 (Direct) |
View |
2024-11-14 Conversion |
2025-03-31 08:17 am |
N/A N/A |
Glucotrack Inc. | GCTK | Malave Luis Director |
214,831 | $214,831 | 357,389 (Direct) |
View |
2024-11-14 Option Award |
2025-03-31 08:17 am |
2030-01-03 2027-07-03 |
Glucotrack Inc. | GCTK | Malave Luis Director |
16,971 | $0 | 357,389 (Direct) |
View |
2024-11-14 Conversion |
2025-03-31 08:17 am |
N/A N/A |
Glucotrack Inc. | GCTK | Malave Luis Director |
6,886 | $31.2 | 357,389 (Direct) |
View |
2025-03-12 Exercise |
2025-03-31 07:52 am |
2030-01-03 2027-07-03 |
Glucotrack Inc. | GCTK | Carter Erin Catherine Director |
42,375 | $0 | 99,788 (Direct) |
View |
2024-11-14 Conversion |
2025-03-31 07:52 am |
N/A N/A |
Glucotrack Inc. | GCTK | Carter Erin Catherine Director |
64,831 | $64,831 | 99,788 (Direct) |
View |
2024-11-14 Option Award |
2025-03-31 07:52 am |
2025-01-03 2030-01-03 |
Glucotrack Inc. | GCTK | Carter Erin Catherine Director |
7,413 | $0 | 99,788 (Direct) |
View |
2024-11-14 Conversion |
2025-03-31 07:52 am |
N/A N/A |
Glucotrack Inc. | GCTK | Carter Erin Catherine Director |
2,078 | $31.2 | 99,788 (Direct) |
View |
2024-11-14 Conversion |
2025-03-28 9:43 pm |
N/A N/A |
Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer |
24,831 | $24,831 | 37,458 (Direct) |
View |
2025-03-12 Exercise |
2025-03-28 9:43 pm |
2025-01-03 2027-07-03 |
Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer |
16,231 | $0 | 37,458 (Direct) |
View |
2024-06-14 Option Award |
2025-03-28 9:43 pm |
N/A 2034-06-14 |
Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer |
4,869 | $0 | 37,458 (Direct) |
View |
2024-11-14 Conversion |
2025-03-28 9:43 pm |
N/A N/A |
Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer |
796 | $31.2 | 37,458 (Direct) |
View |
2025-02-05 Other |
2025-03-28 9:43 pm |
N/A N/A |
Glucotrack Inc. | GCTK | Goode Paul Chief Executive Officer |
1,500 | $0 | 37,458 (Direct) |
View |
2022-10-04 Option Award |
2025-03-28 9:05 pm |
N/A N/A |
Glucotrack Inc. | GCTK | Danzig Allen Director |
1,771 | $0 | 1,922 (Direct) |
View |
2025-03-26 Option Award |
2025-03-28 8:57 pm |
N/A N/A |
Glucotrack Inc. | GCTK | Balo Andrew K Director |
4,490 | $0 | 4,490 (Direct) |
View |
2021-08-24 Option Award |
2025-03-28 8:53 pm |
N/A N/A |
Glucotrack Inc. | GCTK | Fischell Robert Director |
2,045 | $0 | 2,045 (Direct) |
View |
Ownership |
2025-03-28 8:31 pm |
N/A N/A |
Glucotrack Inc. | GCTK | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% Owner |
0 | $0 | 51,002 (Direct) |
View |
Ownership |
2024-11-22 4:09 pm |
N/A N/A |
Glucotrack Inc. | GCTK | BALLANTYNE JOHN Director 10% Owner |
0 | $0 | 1,020,033 (Indirect) |
View |
Ownership |
2024-04-24 9:00 pm |
N/A N/A |
GlucoTrack Inc. | GCTK | Goode Paul Chief Executive Officer |
0 | $0 | 398,820 (Direct) |
View |
Ownership |
2022-08-10 1:12 pm |
N/A N/A |
GlucoTrack Inc. | GCTK | Danzig Allen Director |
0 | $0 | 15,048 (Direct) |
View |